carnitine has been researched along with Angor Pectoris in 26 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among patients with suspected stable angina pectoris, elevated serum even-chained acylcarnitines were associated with increased risk of cardiovascular death and, to a lesser degree with acute myocardial infarction, independent of traditional risk factors." | 7.85 | Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris. ( Berge, RK; Bjørndal, B; Dierkes, J; Karlsson, T; Mellgren, G; Njølstad, PR; Nygård, O; Olsen, T; Pedersen, ER; Strand, E; Svardal, A; Svingen, GF; Tell, GS, 2017) |
| "To evaluate the therapeutic efficacy of l-carnitine in heart failure, the myocardial carnitine levels and the therapeutic efficacy of l-carnitine were studied in cardiomyopathic BIO 14." | 7.68 | L-carnitine treatment for congestive heart failure--experimental and clinical study. ( Kobayashi, A; Masumura, Y; Yamazaki, N, 1992) |
| "L-carnitine was administered orally in doses of 3 g/day for 30 days to 16 subjects with effort-induced angina and to 14 healthy subjects." | 5.27 | Bicycle ergometer and echocardiographic study in healthy subjects and patients with angina pectoris after administration of L-carnitine: semiautomatic computerized analysis of M-mode tracing. ( Biagini, A; Canale, C; Castellano, A; Masperone, MA; Terrachini, V; Valice, S; Vallebona, A, 1988) |
| "Infusions of DL-carnitine are reported to improve the tolerance to atrial pacing of patients with angina pectoris." | 5.05 | Intravenous dl-carnitine fails to increase the double-product during atrial pacing in patients with effort angina. A double-blind randomized study. ( Biagini, A; Carpeggiani, C; Maseri, A; Mazzei, MG; Opie, L; Rovai, D, 1983) |
| "A systematic review and meta-analysis of 13 controlled trials (N=3629) was conducted to determine the effects of L-carnitine vs placebo or control on mortality, ventricular arrhythmias (VAs), angina, heart failure, and reinfarction." | 4.89 | L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. ( DiNicolantonio, JJ; Fares, H; Lavie, CJ; Menezes, AR; O'Keefe, JH, 2013) |
| "Among patients with suspected stable angina pectoris, elevated serum even-chained acylcarnitines were associated with increased risk of cardiovascular death and, to a lesser degree with acute myocardial infarction, independent of traditional risk factors." | 3.85 | Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris. ( Berge, RK; Bjørndal, B; Dierkes, J; Karlsson, T; Mellgren, G; Njølstad, PR; Nygård, O; Olsen, T; Pedersen, ER; Strand, E; Svardal, A; Svingen, GF; Tell, GS, 2017) |
| "To evaluate the therapeutic efficacy of l-carnitine in heart failure, the myocardial carnitine levels and the therapeutic efficacy of l-carnitine were studied in cardiomyopathic BIO 14." | 3.68 | L-carnitine treatment for congestive heart failure--experimental and clinical study. ( Kobayashi, A; Masumura, Y; Yamazaki, N, 1992) |
| "L-carnitine was randomly administered to 81 patients at an oral dose of g 4/die for 12 months, in addition to the pharmacological treatment generally used." | 2.67 | Controlled study on L-carnitine therapeutic efficacy in post-infarction. ( Bigalli, A; Boem, A; Davini, P; Lamanna, F, 1992) |
| "L-carnitine was studied in forty-four men with stable chronic angina in a multicenter, double-blind, randomized, placebo controlled crossover trial." | 2.66 | Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study. ( Angelino, F; Caponnetto, S; Cherchi, A; Lai, C; Manzoli, U; Mereto, PE; Reale, A; Rosolen, G; Schiavoni, G; Trucco, G, 1985) |
| " Unfortunately, there is no reason to believe that these drugs inhibit fat oxidation selectively in the heart; thus, chronic use of these drugs can be expected to increase body fat stores until the original rate of fat oxidation is restored by mass action - presumably negating the therapeutic benefit in angina, while exacerbating the manifold adverse effects of insulin resistance syndrome." | 1.32 | A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets. ( McCarty, MF, 2004) |
| "L-carnitine was administered orally in doses of 3 g/day for 30 days to 16 subjects with effort-induced angina and to 14 healthy subjects." | 1.27 | Bicycle ergometer and echocardiographic study in healthy subjects and patients with angina pectoris after administration of L-carnitine: semiautomatic computerized analysis of M-mode tracing. ( Biagini, A; Canale, C; Castellano, A; Masperone, MA; Terrachini, V; Valice, S; Vallebona, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (30.77) | 18.7374 |
| 1990's | 12 (46.15) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiNicolantonio, JJ | 1 |
| Lavie, CJ | 1 |
| Fares, H | 1 |
| Menezes, AR | 1 |
| O'Keefe, JH | 1 |
| Strand, E | 1 |
| Pedersen, ER | 1 |
| Svingen, GF | 1 |
| Olsen, T | 1 |
| Bjørndal, B | 1 |
| Karlsson, T | 1 |
| Dierkes, J | 1 |
| Njølstad, PR | 1 |
| Mellgren, G | 1 |
| Tell, GS | 1 |
| Berge, RK | 1 |
| Svardal, A | 1 |
| Nygård, O | 1 |
| César, LA | 1 |
| Gowdak, LH | 1 |
| Mansur, AP | 1 |
| McCarty, MF | 1 |
| Sweeney, M | 1 |
| Kamikawa, T | 1 |
| Suzuki, Y | 1 |
| Kobayashi, A | 2 |
| Hayashi, H | 1 |
| Masumura, Y | 2 |
| Nishihara, K | 1 |
| Abe, M | 1 |
| Yamazaki, N | 2 |
| Biagini, A | 2 |
| Opie, L | 1 |
| Rovai, D | 1 |
| Mazzei, MG | 1 |
| Carpeggiani, C | 1 |
| Maseri, A | 1 |
| Ferrari, R | 1 |
| Cucchini, F | 1 |
| Visioli, O | 1 |
| Ribeiro, C | 1 |
| Chierchia, SL | 1 |
| Fragasso, G | 1 |
| Bartels, GL | 4 |
| Remme, WJ | 4 |
| Pillay, M | 2 |
| Schönfeld, DH | 2 |
| Kruijssen, DA | 3 |
| Holwerda, KJ | 1 |
| den Hartog, FR | 1 |
| Wielenga, RP | 1 |
| Iyer, RN | 1 |
| Khan, AA | 1 |
| Gupta, A | 1 |
| Vajifdar, BU | 1 |
| Lokhandwala, YY | 1 |
| Opie, LH | 1 |
| Cherchi, A | 3 |
| Fonzo, R | 1 |
| Lai, C | 3 |
| Mercuro, G | 1 |
| Corsi, M | 2 |
| Davini, P | 1 |
| Bigalli, A | 1 |
| Lamanna, F | 1 |
| Boem, A | 1 |
| Cox, PH | 1 |
| Kruijssen, HA | 1 |
| Knufman, NM | 1 |
| Fernandez, C | 1 |
| Proto, C | 1 |
| Lagioia, R | 1 |
| Scrutinio, D | 1 |
| Mangini, SG | 1 |
| Ricci, A | 1 |
| Mastropasqua, F | 1 |
| Valentini, G | 1 |
| Ramunni, G | 1 |
| Totaro Fila, G | 1 |
| Rizzon, P | 1 |
| Cacciatore, L | 1 |
| Cerio, R | 1 |
| Ciarimboli, M | 1 |
| Cocozza, M | 1 |
| Coto, V | 1 |
| D'Alessandro, A | 1 |
| D'Alessandro, L | 1 |
| Grattarola, G | 1 |
| Imparato, L | 1 |
| Lingetti, M | 1 |
| Onnis, E | 1 |
| Orani, E | 1 |
| Pirisi, R | 1 |
| Pisano, MR | 1 |
| Soro, A | 1 |
| Canale, C | 1 |
| Terrachini, V | 1 |
| Vallebona, A | 1 |
| Masperone, MA | 1 |
| Valice, S | 1 |
| Castellano, A | 1 |
| Angelino, F | 1 |
| Trucco, G | 1 |
| Caponnetto, S | 1 |
| Mereto, PE | 1 |
| Rosolen, G | 1 |
| Manzoli, U | 1 |
| Schiavoni, G | 1 |
| Reale, A | 1 |
| Strano, A | 1 |
| Novo, S | 1 |
| Adamo, L | 1 |
| Raineri, M | 1 |
| Bruno Gallo, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Double Blind Study of the Effects of Homocysteine Lowering Therapy on Mortality and Cardiac Events in Patients Undergoing Coronary Angiography[NCT00354081] | Phase 3 | 3,096 participants (Actual) | Interventional | 1999-04-30 | Completed | ||
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for carnitine and Angor Pectoris
| Article | Year |
|---|---|
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Carnitine; Heart Failure; Humans; Myocardial Infarction; Odds | 2013 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease | 2009 |
Metabolic management of ischaemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Ene | 1993 |
[L-carnitine in the treatment of chronic myocardial ischemia. An analysis of 3 multicenter studies and a bibliographic review].
Topics: Angina Pectoris; Carnitine; Chronic Disease; Coronary Disease; Drug Evaluation; Germany; Humans; Ita | 1992 |
13 trials available for carnitine and Angor Pectoris
| Article | Year |
|---|---|
Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Carnitine; Electrocardiography; Exercise Test; Fatty A | 1984 |
Intravenous dl-carnitine fails to increase the double-product during atrial pacing in patients with effort angina. A double-blind randomized study.
Topics: Angina Pectoris; Cardiac Pacing, Artificial; Carnitine; Coronary Disease; Hemodynamics; Humans; Male | 1983 |
Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.
Topics: Aged; Angina Pectoris; Cardiac Output; Cardiotonic Agents; Carnitine; Coronary Disease; Electrocardi | 1994 |
Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiotonic Agents; Cardiovascular Agents; Carnitine; | 1996 |
Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.
Topics: Adult; Aged; Angina Pectoris; Carnitine; Exercise Test; Female; Humans; Male; Middle Aged; Myocardia | 1995 |
L-carnitine moderately improves the exercise tolerance in chronic stable angina.
Topics: Adult; Analysis of Variance; Angina Pectoris; Carnitine; Chronic Disease; Drug Administration Schedu | 2000 |
Controlled study on L-carnitine therapeutic efficacy in post-infarction.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Carnitine; Fe | 1992 |
[L-carnitine in the treatment of chronic myocardial ischemia. An analysis of 3 multicenter studies and a bibliographic review].
Topics: Angina Pectoris; Carnitine; Chronic Disease; Coronary Disease; Drug Evaluation; Germany; Humans; Ita | 1992 |
Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Carnitine; Coronary Disease; Double-Blind Method; Exer | 1992 |
The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Carnitine; Diltiazem; Female; Humans; Male; Middle Age | 1991 |
Propionyl carnitine in stable effort angina.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Carnitine; Double-Blind Method; | 1990 |
Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
Topics: Angina Pectoris; Blood Pressure; Carnitine; Clinical Trials as Topic; Double-Blind Method; Exercise | 1985 |
[Effects of diltiazem and the combination diltiazem + L-carnitine in patients with exertion angina: a double-blind study with placebo].
Topics: Adult; Angina Pectoris; Benzazepines; Carnitine; Clinical Trials as Topic; Diltiazem; Double-Blind M | 1985 |
10 other studies available for carnitine and Angor Pectoris
| Article | Year |
|---|---|
Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris.
Topics: Aged; Angina Pectoris; Biomarkers; Carnitine; Cause of Death; Follow-Up Studies; Heart Arrest; Human | 2017 |
A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets.
Topics: Acetanilides; Angina Pectoris; Carnitine; Chemotherapy, Adjuvant; Diet, Fat-Restricted; Diet, Vegeta | 2004 |
Effects of very low-fat diets on anginal symptoms.
Topics: Acetanilides; Angina Pectoris; Carnitine; Chemotherapy, Adjuvant; Diabetes Complications; Diabetes M | 2004 |
The metabolical effects of L-carnitine in angina pectoris.
Topics: Angina Pectoris; Blood Glucose; Carnitine; Fatty Acids, Nonesterified; Humans; Lactates; Myocardium | 1984 |
[Therapeutic application of myocardial cytoprotection].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Hum | 1994 |
Role of carnitine in fatty acid metabolism of normal and ischemic myocardium.
Topics: Acetyl Coenzyme A; Acyl Coenzyme A; Angina Pectoris; Atractyloside; Biological Transport; Carnitine; | 1979 |
[The anti-angina action of carnitine].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Carnitine; Electrocardiography; Heart Rate; Humans; Ma | 1978 |
Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans.
Topics: Aged; Angina Pectoris; Blood Pressure; Carnitine; Coronary Disease; Female; Hemodynamics; Humans; In | 1992 |
L-carnitine treatment for congestive heart failure--experimental and clinical study.
Topics: Adult; Angina Pectoris; Animals; Cardiomyopathies; Carnitine; Chronic Disease; Cricetinae; Drug Eval | 1992 |
Bicycle ergometer and echocardiographic study in healthy subjects and patients with angina pectoris after administration of L-carnitine: semiautomatic computerized analysis of M-mode tracing.
Topics: Adult; Angina Pectoris; Carnitine; Echocardiography; Exercise Test; Female; Humans; Male; Middle Age | 1988 |